Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
549.00B | 508.40B | 482.55B | 448.38B | 443.72B | Gross Profit |
151.64B | 141.73B | 128.85B | 113.71B | 105.90B | EBIT |
64.57B | 62.33B | 54.74B | 45.75B | 44.84B | EBITDA |
87.75B | 78.19B | 70.65B | 57.24B | 57.00B | Net Income Common Stockholders |
48.87B | 55.46B | 39.46B | 27.69B | 29.41B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
103.83B | 94.96B | 114.49B | 83.60B | 55.27B | Total Assets |
525.46B | 462.32B | 476.64B | 451.07B | 382.90B | Total Debt |
42.67B | 20.05B | 41.00B | 47.75B | 23.48B | Net Debt |
-60.88B | -74.62B | -73.20B | -35.57B | -31.70B | Total Liabilities |
200.73B | 153.10B | 173.65B | 171.64B | 134.94B | Stockholders Equity |
312.41B | 297.04B | 293.12B | 270.48B | 242.31B |
Cash Flow | Free Cash Flow | |||
43.65B | 23.25B | 40.85B | 11.82B | 22.48B | Operating Cash Flow |
62.58B | 33.63B | 56.13B | 33.34B | 38.57B | Investing Cash Flow |
-32.82B | 11.30B | -3.42B | -17.52B | -26.44B | Financing Cash Flow |
-21.89B | -64.57B | -21.95B | 12.48B | -14.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥373.50B | 24.72 | 1.88% | 7.49% | 1.09% | ||
70 Outperform | ¥250.78B | 23.93 | 2.37% | 9.96% | 16.11% | ||
69 Neutral | $2.47T | 34.46 | 15.31% | 1.59% | 8.65% | 12.22% | |
66 Neutral | $1.09T | 19.30 | 16.17% | 2.62% | 15.49% | 18.42% | |
65 Neutral | $4.15T | 28.34 | 8.51% | 1.03% | 7.95% | 14.53% | |
62 Neutral | ¥973.05B | 19.20 | 1.62% | 3.33% | -5.12% | ||
60 Neutral | $10.78B | 10.47 | -6.71% | 2.99% | 7.58% | -12.08% |